The Assistance Fund (TAF) Duchenne Muscular Dystrophy Financial Assistance Program

The Assistance Fund Duchenne Muscular Dystrophy Financial Assistance Program provides grants for out-of-pocket costs including prescription drugs, health insurance premiums, therapy administration, disease management, genetic testing, and travel expenses (ground, air, meals, hotel) to treatment centers or specialists. To qualify, applicants must be U.S. citizens or permanent residents diagnosed with DMD, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size.

Eligibility

Applicants must be U.S. citizens or permanent residents diagnosed with Duchenne Muscular Dystrophy and prescribed an FDA-approved treatment. Eligibility also requires having prescription coverage and meeting financial criteria based on household income and size.